Journal title
Journal of Crohn's and Colitis
DOI
10.1093/ecco-jcc/jjx180.389
Issue
supplement_1
Volume
12
Last updated
2022-03-06T06:07:26.807+00:00
Page
S233-
Abstract
Disease activity assessment is an essential part of clinical management in UC, most accurately evaluated by endoscopy and biopsy, since patient symptoms may not reliably reflect activity. Published cut-offs for faecal calprotectin (FCal) in UC are largely based on prediction of relapse, rather than prediction of endoscopic or histopathologic activity.
Symplectic ID
844078
Submitted to ORA
On
Publication type
Conference Paper
Publication date
16 January 2018